Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Injecting it can cause pain, swelling, allergic reactions, or infections at the injection site
This product is supplied strictly as a research compound and is not intended for human or veterinary use
TRPV1 Channel Inhibition: Research published in Molecular Immunology (2023) identified a second direct analgesic mechanism ARA-290 specifically inhibits TRPV1 (Transient Receptor Potential Vanilloid 1) channel activity in peripheral nociceptors, increasing the pain threshold and relieving mechanical hypersensitivity independent of its anti-inflammatory IRR actions
The peptide stimulates expression of early growth response 1 (EGR-1) gene, which regulates cytokine and growth factor generation along with early extracellular matrix formation, while simultaneously inducing its repressor NAB2 to prevent excessive angiogenic signaling
US$ 24.85
US$ 28.08
US$ 20.10
US$ 22.51
US$ 29.06
US$ 23.76
US$ 20.49
US$ 24.88
